Carlsmed (CARL) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
22 Apr, 2026Executive summary
Annual meeting scheduled for June 3, 2026, at 8:00 A.M. Pacific Time in San Diego, CA.
Shareholders are encouraged to review proxy materials and vote by June 2, 2026.
Voting can be done online, by mail, or in person at the meeting.
Voting matters and shareholder proposals
Election of two Class I directors, Niall Casey and Philip Young, for a three-year term expiring at the 2029 annual meeting.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Proxy holders may vote on other business that arises at the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of both director nominees and the auditor ratification.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Carlsmed
- Q1 2026 revenue up 58% to $16.1M, gross margin 77.1%, and guidance raised to $72–77M.CARL
Q1 20265 May 2026 - Personalized AI-enabled spine surgery platform drives growth, clinical impact, and premium reimbursement.CARL
Corporate presentation5 May 2026 - Proxy covers director elections, auditor ratification, governance, compensation, and ESG oversight.CARL
Proxy filing22 Apr 2026 - AI-driven personalized spine surgery platform drives strong growth and clinical outcomes.CARL
25th Annual Needham Virtual Healthcare Conference13 Apr 2026 - 2025 revenue surged 86% with expanding margins and strong adoption of new personalized spine solutions.CARL
Q4 202512 Apr 2026 - Personalized spine surgery platform posts 86% annual growth and expands into cervical market.CARL
2026 CG Musculoskeletal Conference2 Mar 2026 - Spine surgery platform expands to cervical, showing 74% fewer reoperations and rapid growth.CARL
Piper Sandler 37th Annual Healthcare Conference4 Dec 2025 - AI-powered spine surgery platform targets $13.4B market with $88M IPO, rapid growth, and ongoing losses.CARL
Registration Filing29 Nov 2025 - AI-driven spine surgery firm targets IPO to fund growth, expand R&D, and scale commercialization.CARL
Registration Filing29 Nov 2025